Comparison of pioglitazone with other antidiabetic drugs for associated incidence of liver failure: no evidence of increased risk of liver failure with pioglitazone

Journal article

R. Rajagopalan, S. Iyer and A. Perez

Diabetes, obesity & metabolism, Vol.7(2), pp.161-169

Received 3 February 2004; returned for revision 15 March 2004; revised version accepted 17 March 2004

03/2005

PMID: 15715889

Abstract

antidiabetic drugs

hepatitis

hepatotoxicity

liver failure

pioglitazone

1 Record Views

Title: Comparison of pioglitazone with other antidiabetic drugs for associated incidence of liver failure: no evidence of increased risk of liver failure with pioglitazone
Creators - without role: R. Rajagopalan - Takeda
S. Iyer - Takeda
A. Perez - Takeda
Publication Details: Diabetes, obesity & metabolism, Vol.7(2), pp.161-169
Publisher: Blackwell Science Ltd
Edition: Received 3 February 2004; returned for revision 15 March 2004; revised version accepted 17 March 2004
Identifiers: 9926192308331
Academic Unit: Prince Sattam Bin Abdulaziz University
Language: English
Resource Type: Journal article